Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway

Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability o...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 9; p. 105
Main Authors Deng, Ran, Li, Feng, Wu, Hong, Wang, Wen-Yu, Dai, Li, Zhang, Zheng-Rong, Fu, Jun
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 15.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs . Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA.
AbstractList Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis, which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all P < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs in vitro. Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA.
Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all P < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs in vitro . Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA.
Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs . Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA.
Author Wang, Wen-Yu
Deng, Ran
Dai, Li
Zhang, Zheng-Rong
Fu, Jun
Li, Feng
Wu, Hong
AuthorAffiliation 1 Key Laboratory of Xin’an Medicine, Ministry of Education , Hefei , China
2 College of Pharmacy, Anhui University of Chinese Medicine , Hefei , China
AuthorAffiliation_xml – name: 2 College of Pharmacy, Anhui University of Chinese Medicine , Hefei , China
– name: 1 Key Laboratory of Xin’an Medicine, Ministry of Education , Hefei , China
Author_xml – sequence: 1
  givenname: Ran
  surname: Deng
  fullname: Deng, Ran
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 2
  givenname: Feng
  surname: Li
  fullname: Li, Feng
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 3
  givenname: Hong
  surname: Wu
  fullname: Wu, Hong
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 4
  givenname: Wen-Yu
  surname: Wang
  fullname: Wang, Wen-Yu
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 5
  givenname: Li
  surname: Dai
  fullname: Dai, Li
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 6
  givenname: Zheng-Rong
  surname: Zhang
  fullname: Zhang, Zheng-Rong
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
– sequence: 7
  givenname: Jun
  surname: Fu
  fullname: Fu, Jun
  organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29497378$$D View this record in MEDLINE/PubMed
BookMark eNpVktFu0zAUhi00xEbZPVcol9ykjePYcbhAChPdKjqYGFxbjnPSeCR2sN2ivAwPwkPwTKTtmDbLkq3j___Okfy_RCfGGkDoNU7mhPBi0QytdPM0wXyeJDihz9AZZozEBcfpyaP7KTr3_i6ZFikKwrIX6DQtsiInOT9Dv0sTdKxN08m-l8G6MboG1UqjfR_ZJroEowfrdQ3vopVpdaWDNpsotBBdjQO4afcgK93pMO71S105W3XSh3itf0B0Oxq701aNAXy00_Lg_NracjEQfl3efFp8XsZ__3xYLONSTejoVm-M7KIbGdpfcnyFnjey83B-f87Q9-XHbxdX8frL5eqiXMcqY2mIQXJWV0wq2chMqXyqNjQjFPOUFwrquoGqwQwTTInKeAXAeAqkgBSTSgEjM7Q6cmsr78TgdC_dKKzU4lCwbiOkC1p1IChOCWNVmijgGaUZx01NGc2B5_X0GWpivT-yhm3VQ63ABCe7J9CnL0a3YmN3gnLMs2miGXp7D3D25xZ8EL32CrpOGrBbL6YuCWF5xukkTY5S5az3DpqHNjgR-5SIQ0r2Fi4OKZksbx6P92D4nwnyD0OfvnQ
CitedBy_id crossref_primary_10_1016_j_intimp_2023_109894
crossref_primary_10_3389_fphar_2022_969408
crossref_primary_10_1016_j_phymed_2022_154068
crossref_primary_10_1007_s43440_020_00068_4
crossref_primary_10_1155_2022_9312611
crossref_primary_10_1016_j_jconrel_2021_03_008
crossref_primary_10_1155_2021_8827891
crossref_primary_10_3389_fphar_2020_584176
crossref_primary_10_1016_j_jtcms_2021_06_001
crossref_primary_10_1007_s40495_019_00177_6
crossref_primary_10_1016_j_jep_2021_114067
crossref_primary_10_1002_ptr_7130
crossref_primary_10_1016_j_jep_2023_117397
crossref_primary_10_1002_ptr_7211
crossref_primary_10_1039_C9RA01448A
crossref_primary_10_1016_j_intimp_2024_112082
crossref_primary_10_1016_j_bcp_2023_115973
crossref_primary_10_1039_C9RA00060G
crossref_primary_10_3389_fphar_2020_569251
crossref_primary_10_1016_j_heliyon_2024_e32705
crossref_primary_10_1016_j_ejphar_2022_175271
crossref_primary_10_1016_j_intimp_2019_106121
crossref_primary_10_1016_j_intimp_2018_09_049
crossref_primary_10_1016_j_phrs_2020_104631
crossref_primary_10_1016_j_jep_2022_115629
crossref_primary_10_1155_2018_7379893
crossref_primary_10_3389_fphar_2019_00411
crossref_primary_10_1002_ptr_6509
crossref_primary_10_1016_j_jnutbio_2020_108555
crossref_primary_10_3390_molecules27103319
crossref_primary_10_1016_j_chemosphere_2018_03_162
crossref_primary_10_1021_acs_jafc_8b00739
crossref_primary_10_3389_fcell_2021_603742
crossref_primary_10_1111_1756_185X_13958
crossref_primary_10_1155_2020_5786053
crossref_primary_10_1016_j_isci_2021_103620
crossref_primary_10_1186_s13020_022_00616_5
crossref_primary_10_3390_cells9061467
crossref_primary_10_1186_s10020_022_00490_9
crossref_primary_10_3389_fphar_2019_00491
crossref_primary_10_1021_acs_jproteome_0c00300
crossref_primary_10_3390_pr9071081
crossref_primary_10_1016_j_jep_2021_113958
crossref_primary_10_1016_j_intimp_2019_105840
Cites_doi 10.1016/j.intimp.2012.07.006
10.1155/2012/948218
10.1155/2017/2405291
10.1177/1535370216631028
10.1007/s12026-016-8794-x
10.1096/fj.15-279802
10.1002/cam4.1019
10.1089/ars.2013.5713
10.1002/art.38327
10.1016/j.bbrc.2016.06.152
10.3389/fphar.2017.00538
10.1016/j.cellbi.2007.01.036
10.1186/1475-2840-11-7
10.1016/j.intimp.2017.03.007
10.1002/art.1780281005
10.1055/s-0031-1298212
10.1007/s00296-012-2383-7
10.1007/s10067-013-2340-1
10.1155/2015/832916
10.1016/j.bbrc.2011.07.031
10.1016/j.molimm.2017.08.024
10.1016/j.virusres.2014.07.027
10.1016/j.coph.2013.02.006
10.1002/ptr.5775
10.1155/2016/3906108
10.18632/oncotarget.17331
10.1002/art.38141
10.3899/jrheum.141292
10.1007/s10753-017-0694-2
10.1016/j.pharep.2015.06.004
10.1002/ptr.5847
10.1093/rheumatology/keq188
10.1016/S1875-5364(15)30087-X
10.1093/rheumatology/keu487
10.1089/jir.2014.0188
10.1038/nature01661
10.1016/j.immuni.2017.02.006
10.1016/j.intimp.2014.02.021
10.2174/1381612820666140825122247
10.1155/2015/387094
10.1038/cddis.2016.490
10.1016/j.cyto.2014.12.027
10.3892/ijmm.2017.2896
10.1371/journal.pone.0170346
10.1016/j.semarthrit.2013.06.001
10.1016/j.intimp.2015.01.001
10.1038/sj.mn.7800149
10.1136/ard.2010.142240
10.1038/s41598-017-17566-w
10.1016/j.biopha.2017.02.045
10.1038/aps.2016.168
10.1016/j.jpba.2015.01.044
ContentType Journal Article
Copyright Copyright © 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu. 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu
Copyright_xml – notice: Copyright © 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu. 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fphar.2018.00105
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1663-9812
EndPage 105
ExternalDocumentID oai_doaj_org_article_512366b20ce8455481fd5657e87d201c
10_3389_fphar_2018_00105
29497378
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81073122
– fundername: National Natural Science Foundation of China
  grantid: 81473400
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
ITC
5PM
ID FETCH-LOGICAL-c462t-ea86db6acafa4cc7c46f543518289ceddfebf1613153c48bee682e39e213bce63
IEDL.DBID RPM
ISSN 1663-9812
IngestDate Fri Oct 04 13:14:28 EDT 2024
Tue Sep 17 21:25:26 EDT 2024
Sat Aug 17 00:43:48 EDT 2024
Thu Sep 26 19:00:07 EDT 2024
Wed Oct 16 00:59:53 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-ea86db6acafa4cc7c46f543518289ceddfebf1613153c48bee682e39e213bce63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Wei Wei, Anhui Medical University, China
Reviewed by: Youcai Deng, Third Military Medical University, China; Huichang Bi, Sun Yat-sen University, China; Yan Huang, Anhui Medical University, China
These authors have contributed equally to this work and are co-first authors.
This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818421/
PMID 29497378
PQID 2010367485
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_512366b20ce8455481fd5657e87d201c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5818421
proquest_miscellaneous_2010367485
crossref_primary_10_3389_fphar_2018_00105
pubmed_primary_29497378
PublicationCentury 2000
PublicationDate 2018-02-15
PublicationDateYYYYMMDD 2018-02-15
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-15
  day: 15
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2018
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Lubberts (B23) 2015; 21
Ni (B28) 2017; 12
Xu (B49) 2017; 38
Wang (B43) 2015; 8
Walsh (B39) 2010; 49
Xiaofeng (B48) 2012; 78
Filer (B12) 2013; 13
Firestein (B14) 2017; 46
Liu (B22) 2017; 91
Dai (B8) 2014; 20
Byng-Maddick (B1) 2015; 54
Pan (B29) 2017
Chen (B5) 2015; 108
Singer (B34) 1985; 28
Wang (B41) 2017; 31
Wang (B42) 2017; 89
Ng (B27) 2015; 35
Kawanami (B17) 2011; 411
Zhuang (B55) 2017; 8
Yin (B50) 2016; 477
Wu (B46) 2008; 14
Wei (B44) 2017; 46
See (B33) 2013; 43
Dasgupta (B9) 2017; 6
Zou (B56) 2016; 68
Dong (B11) 2017; 8
Tan (B38) 2017; 2017
Dong (B10) 2015; 2015
Li (B21) 2013; 32
Kim (B18) 2017; 8
Suzuki (B36) 2015; 42
Ganesan (B16) 2016; 64
Zhang (B54) 2017; 31
Wang (B40) 2012; 11
Poli (B30) 2002; 9
Criado (B7) 2014; 66
Firestein (B13) 2003; 423
Chakera (B2) 2012; 2012
Wei (B45) 1986; 2
Yu (B52) 2016; 241
Monickaraj (B26) 2016; 30
Puthenedam (B31) 2007; 31
Connolly (B6) 2011; 70
Kong (B19) 2016; 2016
Mankia (B25) 2015; 20
Qian (B32) 2017; 7
Xiao (B47) 2013; 33
Fu (B15) 2012; 14
Zhang (B53) 2014; 192
Lv (B24) 2015; 13
Chang (B3) 2015; 24
Chen (B4) 2015; 2015
Yokota (B51) 2017; 39
Krabben (B20) 2013; 65
Stanley (B35) 2014; 20
Talaat (B37) 2015; 72
References_xml – volume: 14
  start-page: 792
  year: 2012
  ident: B15
  article-title: Geniposide, from Gardenia jasminoides Ellis, inhibits the inflammatory response in the primary mouse macrophages and mouse models.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2012.07.006
  contributor:
    fullname: Fu
– volume: 2012
  year: 2012
  ident: B2
  article-title: The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target.
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2012/948218
  contributor:
    fullname: Chakera
– volume: 2017
  year: 2017
  ident: B38
  article-title: Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis.
  publication-title: Mdiators Inflamm.
  doi: 10.1155/2017/2405291
  contributor:
    fullname: Tan
– volume: 241
  start-page: 800
  year: 2016
  ident: B52
  article-title: Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytes.
  publication-title: Exp. Biol. Med.
  doi: 10.1177/1535370216631028
  contributor:
    fullname: Yu
– volume: 20
  start-page: 129
  year: 2015
  ident: B25
  article-title: Is localized autoimmunity the trigger for rheumatoid arthritis unravelling new targets for prevention.
  publication-title: Discov. Med.
  contributor:
    fullname: Mankia
– volume: 64
  start-page: 1071
  year: 2016
  ident: B16
  article-title: Majoon ushba, a polyherbal compound, suppresses pro-inflammatory mediators and RANKL expression via modulating NFκB and MAPKs signaling pathways in fibroblast-like synoviocytes from adjuvant-induced arthritic rats.
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-016-8794-x
  contributor:
    fullname: Ganesan
– volume: 30
  start-page: 1670
  year: 2016
  ident: B26
  article-title: Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.
  publication-title: FASEB J.
  doi: 10.1096/fj.15-279802
  contributor:
    fullname: Monickaraj
– volume: 6
  start-page: 809
  year: 2017
  ident: B9
  article-title: Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway.
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1019
  contributor:
    fullname: Dasgupta
– volume: 20
  start-page: 2026
  year: 2014
  ident: B35
  article-title: NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration.
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2013.5713
  contributor:
    fullname: Stanley
– volume: 66
  start-page: 1208
  year: 2014
  ident: B7
  article-title: Alternative p38 MAPKs are essential for collagen-induced arthritis.
  publication-title: Arthritis Rheumatol.
  doi: 10.1002/art.38327
  contributor:
    fullname: Criado
– volume: 477
  start-page: 881
  year: 2016
  ident: B50
  article-title: Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2016.06.152
  contributor:
    fullname: Yin
– volume: 8
  year: 2017
  ident: B55
  article-title: Tamarixinin A alleviates joint destruction of rheumatoid arthritis by blockade of MAPK, and NF-kB activation.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2017.00538
  contributor:
    fullname: Zhuang
– volume: 31
  start-page: 836
  year: 2007
  ident: B31
  article-title: Modulation of tight junction barrier function by outer membrane proteins of enteropathogenic Escherichia coli: role of F-actin and junctional adhesion molecule-1.
  publication-title: Cell Biol. Int.
  doi: 10.1016/j.cellbi.2007.01.036
  contributor:
    fullname: Puthenedam
– volume: 11
  year: 2012
  ident: B40
  article-title: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
  publication-title: Cardiovasc. Diabetol.
  doi: 10.1186/1475-2840-11-7
  contributor:
    fullname: Wang
– volume: 46
  start-page: 220
  year: 2017
  ident: B44
  article-title: Anti-inflammatory mechanism of ulinastatin: inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2017.03.007
  contributor:
    fullname: Wei
– volume: 28
  start-page: 1105
  year: 1985
  ident: B34
  article-title: Extracellular matrix-cytoskeletal interactions in rheumatoid arthritis. I. Immunoelectron microscopic analysis of the fibronexus at the adhesive surface of normal porcine type B synoviocytes in vitro.
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.1780281005
  contributor:
    fullname: Singer
– volume: 78
  start-page: 557
  year: 2012
  ident: B48
  article-title: Geniposide, an iridoid glucoside derived from Gardenia jasminoides, protects against lipopolysaccharide-induced acute lung injury in mice.
  publication-title: Planta Med.
  doi: 10.1055/s-0031-1298212
  contributor:
    fullname: Xiaofeng
– volume: 33
  start-page: 389
  year: 2013
  ident: B47
  article-title: Inhibitory effects of simvastatin on migration and invasion of rheumatoid fibroblast-like synoviocytes by preventing geranylgeranylation of RhoA.
  publication-title: Rheumatol. Int.
  doi: 10.1007/s00296-012-2383-7
  contributor:
    fullname: Xiao
– volume: 32
  start-page: 1697
  year: 2013
  ident: B21
  article-title: A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis.
  publication-title: Clin. Rheumatol.
  doi: 10.1007/s10067-013-2340-1
  contributor:
    fullname: Li
– volume: 2015
  year: 2015
  ident: B10
  article-title: Effect of leflunomide on the abnormal expression of lipid rafts and F-Actin in B lymphocytes from patients with systemic lupus erythematosus.
  publication-title: J. Immunol. Res.
  doi: 10.1155/2015/832916
  contributor:
    fullname: Dong
– volume: 411
  start-page: 798
  year: 2011
  ident: B17
  article-title: Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells.
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2011.07.031
  contributor:
    fullname: Kawanami
– volume: 91
  start-page: 24
  year: 2017
  ident: B22
  article-title: NLRC5 promotes cell proliferation via regulating the NF-κB signaling pathway in Rheumatoid arthritis.
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2017.08.024
  contributor:
    fullname: Liu
– volume: 192
  start-page: 6
  year: 2014
  ident: B53
  article-title: p38MAPK, Rho/ROCK and PKC pathways are involved in influenza-induced cytoskeletal rearrangement and hyperpermeability in PMVEC via phosphorylating ERM.
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2014.07.027
  contributor:
    fullname: Zhang
– volume: 13
  start-page: 413
  year: 2013
  ident: B12
  article-title: The fibroblast as a therapeutic target in rheumatoid arthritis.
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/j.coph.2013.02.006
  contributor:
    fullname: Filer
– volume: 31
  start-page: 631
  year: 2017
  ident: B41
  article-title: Antiinflammation effects and mechanisms study of geniposide on rats with collagen induced arthritis.
  publication-title: Phytother. Res.
  doi: 10.1002/ptr.5775
  contributor:
    fullname: Wang
– volume: 2016
  year: 2016
  ident: B19
  article-title: Anti-inflammatory effects of TRAF-interacting protein in rheumatoid arthritis fibroblast-like synoviocytes.
  publication-title: Mediators Inflamm.
  doi: 10.1155/2016/3906108
  contributor:
    fullname: Kong
– volume: 8
  start-page: 50958
  year: 2017
  ident: B11
  article-title: EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway.
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17331
  contributor:
    fullname: Dong
– volume: 65
  start-page: 3051
  year: 2013
  ident: B20
  article-title: Genetic variants in the IL-4 and IL-4 receptor genes in association with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.38141
  contributor:
    fullname: Krabben
– volume: 42
  start-page: 943
  year: 2015
  ident: B36
  article-title: Upregulation of thrombospondin 1 expression in synovial tissues and plasma of rheumatoid arthritis: role of transforming growth factor-β1 toward fibroblast-like synovial cells.
  publication-title: J. Rheumatol.
  doi: 10.3899/jrheum.141292
  contributor:
    fullname: Suzuki
– volume: 8
  start-page: 14562
  year: 2015
  ident: B43
  article-title: MiR-451 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion in rheumatoid arthritis through mediating p38MAPK signaling pathway.
  publication-title: Int. J. Clin. Exp. Pathol.
  contributor:
    fullname: Wang
– year: 2017
  ident: B29
  article-title: Geniposide suppresses interleukin-1β-induced inflammation and apoptosis in rat chondrocytes via the PI3K/Akt/NF-κB signaling pathway.
  publication-title: Inflammation
  doi: 10.1007/s10753-017-0694-2
  contributor:
    fullname: Pan
– volume: 68
  start-page: 7
  year: 2016
  ident: B56
  article-title: β-Elemene induces apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes via reactive oxygen species-dependent activation of p38 mitogen-activated protein kinase.
  publication-title: Pharmacol. Rep.
  doi: 10.1016/j.pharep.2015.06.004
  contributor:
    fullname: Zou
– volume: 31
  start-page: 1249
  year: 2017
  ident: B54
  article-title: Immune tolerance effect in mesenteric lymph node lymphocytes of geniposide on adjuvant arthritis rats.
  publication-title: Phytother. Res.
  doi: 10.1002/ptr.5847
  contributor:
    fullname: Zhang
– volume: 49
  start-page: 1852
  year: 2010
  ident: B39
  article-title: Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis.
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keq188
  contributor:
    fullname: Walsh
– volume: 13
  start-page: 831
  year: 2015
  ident: B24
  article-title: Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways.
  publication-title: Chin. J. Nat. Med.
  doi: 10.1016/S1875-5364(15)30087-X
  contributor:
    fullname: Lv
– volume: 54
  start-page: 768
  year: 2015
  ident: B1
  article-title: The impact of biological therapy on regulatory T cells in rheumatoid arthritis.
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu487
  contributor:
    fullname: Byng-Maddick
– volume: 14
  start-page: 49
  year: 2008
  ident: B46
  article-title: Effects and mechanisms of treating adjuvant arthritis by total glucosides of cape jasmine in rat.
  publication-title: Chin. J. Exp. Tradit. Med. Formul.
  contributor:
    fullname: Wu
– volume: 35
  start-page: 513
  year: 2015
  ident: B27
  article-title: Interferon-gamma increases endothelial permeability by causing activation of p38 MAP kinase and actin cytoskeleton alteration.
  publication-title: J. Interferon Cytokine Res.
  doi: 10.1089/jir.2014.0188
  contributor:
    fullname: Ng
– volume: 423
  start-page: 356
  year: 2003
  ident: B13
  article-title: Evolving concepts of rheumatoid arthritis.
  publication-title: Nature
  doi: 10.1038/nature01661
  contributor:
    fullname: Firestein
– volume: 46
  start-page: 183
  year: 2017
  ident: B14
  article-title: Immunopathogenesis of rheumatoid arthritis.
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.02.006
  contributor:
    fullname: Firestein
– volume: 20
  start-page: 46
  year: 2014
  ident: B8
  article-title: Effects and mechanisms of geniposide on rats with adjuvant arthritis.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2014.02.021
  contributor:
    fullname: Dai
– volume: 21
  start-page: 142
  year: 2015
  ident: B23
  article-title: Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment.
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612820666140825122247
  contributor:
    fullname: Lubberts
– volume: 2015
  year: 2015
  ident: B4
  article-title: Suppression of inflammation and arthritis by orally administrated cardiotoxin from Naja naja atra.
  publication-title: Evid. Based Complement. Alternat. Med.
  doi: 10.1155/2015/387094
  contributor:
    fullname: Chen
– volume: 8
  year: 2017
  ident: B18
  article-title: IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy.
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2016.490
  contributor:
    fullname: Kim
– volume: 72
  start-page: 146
  year: 2015
  ident: B37
  article-title: Th1/Th2/Th17/Treg cytokinein systemic lupus erythematosus (SLE) patients: correlation with disease activity.
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2014.12.027
  contributor:
    fullname: Talaat
– volume: 2
  start-page: 29
  year: 1986
  ident: B45
  article-title: Pharmacological effects of isoxicam.
  publication-title: Chin. Pharmacol. Bull.
  contributor:
    fullname: Wei
– volume: 39
  start-page: 799
  year: 2017
  ident: B51
  article-title: ROCK/actin/MRTF signaling promotes the fibrogenic phenotype of fibroblast-like synoviocytes derived from the temporomandibular joint.
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2017.2896
  contributor:
    fullname: Yokota
– volume: 12
  year: 2017
  ident: B28
  article-title: TNFα alters occludin and cerebral endothelial permeability: role of p38MAPK.
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0170346
  contributor:
    fullname: Ni
– volume: 43
  start-page: 381
  year: 2013
  ident: B33
  article-title: Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study.
  publication-title: Semin. Arthritis Rheum.
  doi: 10.1016/j.semarthrit.2013.06.001
  contributor:
    fullname: See
– volume: 24
  start-page: 451
  year: 2015
  ident: B3
  article-title: Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2015.01.001
  contributor:
    fullname: Chang
– volume: 9
  start-page: 419
  year: 2002
  ident: B30
  article-title: Contribution of F-Actin to barrier properties of the blood-joint pathway.
  publication-title: Microcirculation
  doi: 10.1038/sj.mn.7800149
  contributor:
    fullname: Poli
– volume: 70
  start-page: 1296
  year: 2011
  ident: B6
  article-title: Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis.
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.2010.142240
  contributor:
    fullname: Connolly
– volume: 7
  year: 2017
  ident: B32
  article-title: Effect of qianghuo erhuang decoction on T regulatory and T helper 17 cells in treatment of adjuvant-induced arthritis in rats.
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-17566-w
  contributor:
    fullname: Qian
– volume: 89
  start-page: 426
  year: 2017
  ident: B42
  article-title: A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis.
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.02.045
  contributor:
    fullname: Wang
– volume: 38
  start-page: 688
  year: 2017
  ident: B49
  article-title: Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function.
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2016.168
  contributor:
    fullname: Xu
– volume: 108
  start-page: 122
  year: 2015
  ident: B5
  article-title: Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2015.01.044
  contributor:
    fullname: Chen
SSID ssj0000399364
Score 2.4207666
Snippet Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions...
Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis , which is a promising anti-inflammatory drug, but...
Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis, which is a promising anti-inflammatory drug, but...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 105
SubjectTerms Pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQlL8FioyEKiE1Ckkcx8stRYTlZ6sVbaXeItsZsxHaZNVNi_IyPAgPwTMx42zbXYTEBSmnxJEdz3jmm8z4M2MvM1VJKSITKOcUkWrjkoohDrQifqVEJxLof8f0SE5Oxcez9GzjqC-qCRvogYeJC1OiB5Emfm1BCfR9KnIVpepAZRU6L-utb5RuBFPeBpPflWLIS2IUNg7dcq6J_zOi2smITqvb8EOerv9vGPPPUskN31PcZXfWoJHnw2DvsVvQ7LL92cA63R_wk5tNVKsDvs9nN3zU_X32I2-6OkBNQuEvfFKdT4E2_NarBW8dfw9NTbVbFbzhH5p5bWoqheaIDPkEo9RzvBYw0Hn31L7ACLs1iLq74HP9Dfhx37SXdWt7RK38stb-zS_zNg-XiZrms0_hURH8-nkYFkGO1rXhx_VX-pwZgs_vun_ATot3J28nwfpYhsAKGXcBaCUrI7XVTgtrM7zrUkRdEQVvFqrKgXEIJBM0plYoAyBVDMkY4igxFmTykO00bQOPGc_GxiFgjAGjHiF0pbWig-_R5kVVZTWM2KsrIZXLgX2jxKiFBFp6gZYk0NILdMQOSYrX7Yg3299AbSrX2lT-S5tG7MWVDpS4zih5ohtoL1bUETr7TCjs6NGgE9ddxWMxzpJMjVi2pS1bY9l-0tRzz-WdImAScfTkfwz-KbtN00E15VH6jO105xewh5CpM8_96vgNwHsXGg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bjtMwELXQ8sIL4k6Xi4yEVkJaU5I4iYOEUBYRyqWrit1K-xY5zmRrQZPSZhfyM3wIH8E3MZNktxT1BSkvcZw4zsx4zsTjY8aehioPAulkQhWFIlJtNCkXXKEV8St52guA_neMD4PRVH448U_Wy6P7D7jaGtrRflLT5dfnP741r9HgX1HEif52WCxmmqg9HUqLdIjQ9KorPUn6Pu7Bfjsuky9u-aQcdLMiQtfWzVtufciGn2rp_Ldh0H9TKf_yTckNdr0HlTzutOAmuwLlLbY36Vipm31-vF5ktdrne3yy5qtubrOfcVlbgX1H5Zi3k-58DLQg2K7mvCr4Oygt5Xbl8JK_L2c2s5QqzRE58hFGsUs85tDRfTdUP8EIvMoQldfik_0C_Kgpq3NbmQZRLT-3ur3z86yKhwtPjePJx-FhIn7_OhgmIsbRt-RH9pS6M0Fw-l03d9g0eXv8ZiT6bRuEkYFbC9AqyLNAG11oaUyIpYWPqMyh4M5AnheQFQg0PRxsjVQZQKBc8CJwHS8zEHh32U5ZlXCf8TDKCgSULmBUJKXOtVYYPSOC8pw8NxoG7NmFkNJFx86RYlRDAk1bgaYk0LQV6IAdkBQv6xGvdltQLU_T3kxTn8hogsx9YUBJRFrKKXKaGAYV5vgoM2BPLnQgRTukyRVdQnW2ooYQDIRSYUP3Op24bMqNZBR6oRqwcENbNt5l80ppZy3Xt4-ASrrO7n909AG7RieUWu74D9lOvTyDR4ic6uxxaxB_AHpLGXw
  priority: 102
  providerName: Scholars Portal
Title Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway
URI https://www.ncbi.nlm.nih.gov/pubmed/29497378
https://search.proquest.com/docview/2010367485
https://pubmed.ncbi.nlm.nih.gov/PMC5818421
https://doaj.org/article/512366b20ce8455481fd5657e87d201c
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLa2XXGDGL-FMRkJTUJaFpI4jstdN1HKT6eKbdLuIsc5WS2oU7XdUF6GB-EheCbOcdqtRVwhRblInDjJ-ezznfj4M2OvM1VKKaIiUFWlSFQbm1QMcaAV6SslOpFA_zuGp3JwIT5dppdbLF3NhfFJ-6awR-775MjZsc-tnE5MuMoTC0fDkxS9jIijcJttZ0myFqL77pdcrhTtkCQGYN2wmo41SX9GlDaJfIIEgLuimyW0ttqaN_Ki_f9imn8nTK55oP4Ddn9JHXmvfcRdtgXuITsYtdrTzSE_v5tKNT_kB3x0p0rdPGI_e25hA8QTQmDih9b5EGjar51PeF3xD-AsZXCV8I5_dGNbWEqI5sgP-QBj1RluE2hFvRsq38c4uy6Qey-CL_Yb8LPG1Te2Ng1yV35jtb_y67juhdNEDXujz-FpP_j96zjsBz3sYx0_s1f0OiOkoD9085hd9N-fnwyC5eIMgREyXgSglSwLqY2utDAmw6NVitwrohDOQFlWUFRIJxPsUo1QBYBUMSRdiKOkMCCTJ2zH1Q6eMZ51iwppYwwY-wihS60VxsjIk5KoLI2GDnuzMlI-bTU4coxdyLa5t21Ots29bTvsmKx4W47Us_2BenaVLzGUpyQ5I4v4rQElkE-pqCpp-BdUVuKtTIe9WmEgx9ZGQyjaQX09p4rQ5WdCYUVPW0zcVrXCVIdlG2jZeJbNMwhwr-i9BPTz_77yBbtH34DSyaN0j-0sZtfwEtnSotj3fxlwPxRq37eUPyXoGs0
link.rule.ids 230,315,733,786,790,870,891,2115,24346,27955,27956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbpswGLW67mK72f9P9utJU6VJJQww4OwurZalaxJFazv1Dtnmo0FdIEpIJ_Ywe5A9xJ5p3wehTardbBJXGLANx_b58PExY29DGQeBcLQlk0SSqTY2KRdcS0nyV_KUFwD97xiOgv6J-Hzqn24xv1kLU4n2jU7b2bdpO0snlbZyNjV2oxOzx8N9H0cZ4Tr2DXYT26vrrwXpVQdMg24g6klJDME6djKbKDL_dEg4iYyCLIA7ohN6tLva2nhU2fb_jWtel0yujUG9u-xrU_paenLeXha6bX5cM3b85-rdY3dWrJR36-T7bAuyB2xnXNtal7v8-GqV1mKX7_DxleF1-ZD97GZFaiFUEV3TataeD4FWFKeLKc8T_gmylMRhMXzgB9kk1SlprTlST97HMHiOxxRqv_CSru9hCJ9rpPWFNUjPgR-VWX6R5qZEWswvUlXd-WWSd-2ZJ4fd8aE96lm_f-3ZPauL3XfGj9Izqs4Y2e13VT5iJ72Px_t9a7Xvg2VE4BYWKBnEOlBGJUoYE-LZxEda51B0aCCOE9AJMlUPe2sjpAYIpAteB1zH0wYC7zHbzvIMnjIednSCjNQFDKuEULFSEsNvpGCeE8dGQYu9a75-NKvtPSIMiwg0UQWaiEATVaBpsT2Cx-V1ZMxdncjnZ9Hq-0U-udkE2n1vQAqkatJJYppZBhnG-CjTYm8acEXYkGl2RmWQLxeUEbKJUEjM6EkNtsusGrC2WLgBw42ybKYguCqz8BWYnv33na_Zrf7xcBANDkaHz9lteh-kWnf8F2y7mC_hJZKyQr-qmuAf-XI68Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwGLVgSIib8Q_l10hoEtLSkMRNXO66QejYWkVskyZuItv5skZbk6pNh8LD8CA8BM_E9yXt1k5cTcqV48RxcmyfLz4-Zux9IBPfF462ZJpKMtXGJuWCaylJ_kqe8nyg_x2Dod8_Ft9OOicrW33Von2js3Z-Pm7n2ajWVk7Gxl7qxOxosNvBUUa4jj1JUvs2u4Nt1g1WAvW6E6aB1xfNxCSGYV07nYwUGYA6JJ5EVkE2wF3RDTzaYW1lTKqt-__HN6_LJlfGofA--7GsQSM_OWvPS902v66ZO96oig_Y5oKd8l6T5SG7BfkjthU19tbVNj-6Wq012-ZbPLoyvq4es9-9vMwshCyibFzP3vMB0MribDbmRcq_Qp6RSCyBT3wvH2U6I801RwrK-xgOT_EYQ-MbXlH-EEP5QiO9L62D7Az4YZUXF1lhKqTH_CJT9ZXfR0XPnnhy0Iv27WFo_f2zY4dWD7vxnB9mp1SdCFnuT1U9Ycfhl6PdvrXY_8EywndLC5T0E-0ro1IljAkwNe0gvXMoSjSQJCnoFBmrh722EVID-NIFrwuu42kDvveUbeRFDs8ZD7o6RWbqAoZXQqhEKYlhOFIxz0kSo6DFPiwREE8am48YwyMCTlwDJybgxDVwWmyHIHKZjwy664RiehovvmHcIVcbX7sfDUiBlE06aUIzzCCDBG9lWuzdEmAxNmiapVE5FPMZFYSsIhASC3rWAO6yqCVgWyxYg-Las6yfQYDVpuELQL248ZVv2d3ocxgf7A33X7J79DpIvO50XrGNcjqH18jNSv2mboX_AKCGPXE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-inflammatory+Mechanism+of+Geniposide%3A+Inhibiting+the+Hyperpermeability+of+Fibroblast-Like+Synoviocytes+via+the+RhoA%2Fp38MAPK%2FNF-%CE%BAB%2FF-Actin+Signal+Pathway&rft.jtitle=Frontiers+in+pharmacology&rft.au=Deng%2C+Ran&rft.au=Li%2C+Feng&rft.au=Wu%2C+Hong&rft.au=Wang%2C+Wen-yu&rft.date=2018-02-15&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=9&rft_id=info:doi/10.3389%2Ffphar.2018.00105&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fphar_2018_00105
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon